Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks
Condition(s):Hereditary AngioedemaLast Updated:June 8, 2021Completed
Hide Studies Not Open or Pending
Condition(s):Hereditary AngioedemaLast Updated:June 8, 2021Completed
Condition(s):Diabetes MellitusLast Updated:April 4, 2013Completed
Condition(s):Ulcerative ColitisLast Updated:December 18, 2008Completed
Condition(s):Arthritis, RheumatoidLast Updated:November 5, 2014Terminated
Condition(s):Type I HypersensitivityLast Updated:June 17, 2010Completed
Condition(s):Arthritis, RheumatoidLast Updated:October 30, 2018Completed
Condition(s):Atrial Fibrillation; Atrial FlutterLast Updated:July 3, 2018Completed
Condition(s):Diabetes; Diabetes Mellitus, Type 2Last Updated:September 5, 2018Terminated
Condition(s):Breast CancerLast Updated:September 18, 2017Unknown status
Condition(s):T Acute Lymphoblastic Leukemia; T Lymphoblastic LymphomaLast Updated:February 1, 2024Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.